The LEO Foundation plans to double its prize for skin disease research. 

Reporting a successful year in 2023, the LEO Foundation has announced its goals and aspirations out to 2030, including the awarding of a prestigious 5 million Danish kroner prize to a distinguished researcher in Denmark contributing to skin research.

The Foundation plans to double its philanthropic grants for independent research to approximately 500 million kroner annually by 2030, emphasizing the importance of understanding the underlying causes and mechanisms of skin diseases, according to a press release. Additionally, it aims to bolster support for education and awareness initiatives to nurture future researchers and strengthen the skin research ecosystem.

In addition to its focus on skin health, the Foundation prioritizes sustainable development and diversified investments. With assets totaling around 16.5 billion kroner, it aims to generate attractive returns while upholding principles of sustainability, good governance, diversity, and inclusion.

“The LEO Foundation builds on a rich history, with research into and treatment of skin diseases at its heart,” said CEO Peter Haahr, in a press release. “As an enterprise foundation, we have a unique opportunity to make a difference: through our philanthropic activities, which strengthen our fundamental knowledge and understanding of the skin and its diseases through support for independent research, and via our engaged ownership of LEO Pharma, which contributes to advancing the standard of care for the benefit of people living with skin diseases.”

Source: LEO Foundation news release. March 25, 2024.